In children, non-Hodgkin's lymphomas (NHL) are highly malignant diseases with a poor prognosis because of frequent relapse or transformation to acute leukaemia. Following work in the late 1960s (Aur et al., 1971 ) the concept that childhood lymphomas are potentially widespread from the time of diagnosis became accepted. In accordance with this new approach, in 1974 the Children's Solid Tumour Group of St Bartholomew's and the Royal Marsden Hospital designed a protocol for treating children with NHL. This was based on multiple chemotherapeutic induction of remission, prophylaxis of the central nervous system (CNS) and a continuation of therapy with a variety of agents to prevent the emergence of drug resistance and aid the complete elimination of all tumour cells. Sufficient time has now elapsed since the introduction of this intensive treatment programme to evaluate its impact on survival and possible cure of these children.
PATIENTS AND METHODS
A total of 34 patients Awere admitted to this study between September 1974 and June 1977. Five patients are excluded from this analysis, including 3 patients who were lost to follow-up: 1 at 1 mnonth with his original disease and 2 in continuous first complete remissions at 18 and 30 months. The other 2 patients were found (on reviewing the histology) to have had inappropriate treatment according to this protocol. The 29 patients studied included 22 boys and 7 girls, a male to female ratio of 341:1. They ranged from 2 to 14 years of age (median 8).
Diagnosis was made on histology of tissue biopsies. Cases were classified according to Rappaport (1966) . All showed a diffuse pattern, with 26 patients having poorly differentiated lymphoblastic infiltration, 1 histiocytic and 2 with true malignant histiocytosis. The histology was reviewed recently and reclassified according to Lennert's (1978) modification of the Kiel classification. All were then high-grade lymphomas: 26 were lymphoblastic, with 10 morphologically suggesting B type, 6 with convoluted nuclei suggesting T type and 10 undefined. One child had a histiocytic lymphoma and there were 2 immunoblastic lymphomas. The relationship of histology to primary site is shown in Table I . The treatment scheme is shown in Fig. 1 , and is very similar to regimens used for acute leukaemia. It depended on both the stage and histology at diagnosis. Patients with Stage I disease, unless it was affecting the mediastinum, were to receive radiotherapy only. Patients with mediastinal or more widespread disease were to receive chemotherapy. If the histology was diffuse lymphoblastic, poorly differentiated, they received a multidrug scheme (shown in Figs 2 and 3) involving induction, cranial prophylaxis by cranial irradiation and intrathecal (i.t.) drugs, and maintenance. Maintenance (Fig. 3) consisted of a repeating 8-week module, with 6 weeks of oral drugs and intensification with i.v. drugs in the 7th week, followed by one week off therapy. This continued for 3 years. All other diffuse histological types were treated with 6 courses of cyclophosphamide, Adriamycin, vincristine and prednisolone (CHOP), which were repeated 3-weekly. Two patients received radiotherapy only, 3 received 6 courses of CHOP and 22 were treated with the intensive regimen. A series of consecutive patients from the records of St Bartholomew's Hospital was used for comparison with the study patients. These children were treated between May 1962 and February 1973. There were 20 patients, 16 boys and 4 girls, with ages 1-14 years (median 8). Their sites and stages of disease at presentation are shown in Table V. A range of histological classification systems was used when patients were diagnosed, but 16 of the original slides were available for
RESULTS
The disease-free survival of the 2 groups of patients is compared in Fig. 4 (Murphy & Hustu, 1980; Wollner et al., 1979; Brecher et al., 1978; Carabell et al., 1978 (Lennert, 1978) . If the relationship between the primary site at presentation and the histology is examined, an interesting picture emerges (Table I The use of the Ann Arbor staging system in childhood NHL was common at the time this study began, but the marked differences in the natural history of NHL and Hodgkin's disease make it unsuitable. The comparison of survival of early-and late-stage patients in Fig. 5 demonstrates the low prognostic value of the Ann Arbor system. The alternative scheme suggested by Murphy and used at St Jude Hospital, in which the most significant change is that all intrathoracic and extensive abdominal disease become Stage III, appears to be more valuable in predicting the longterm outcome. Our results confirm those of other series, in that patients with strictly localized disease have a markedly better outlook (Murphy, 1980) . These children may well benefit from a less intensive treatment programme without losing their good prognosis.
In conclusion, the present study confirms the improvement in outlook for children with NHL. Staging is more helpful if a system which takes into account the natural history of the disease, such as Murphy's, is used. Basic differences between those children presenting with abdominal and those with mediastinal and nodal disease are suggested by the histology and pattern of outcome, which are now being confirmed with the use of immunological typing and are reflected in the development of current protocols. 
